May 20, 2021
Video
Join Ahmed Obeidat, MD, PhD; Mitchell Freedman, MD; and Suma Shah, MD, for the second program of this monthly series as they discuss the evolution of therapeutics for the treatment of multiple sclerosis.
NeurologyLive® Brain Games: May 22, 2022
New Research Highlights Reasons, Risk Factors, and Consequences for Self-Discontinuation of Antiseizure Medication in Newly Diagnosed Epilepsy
New Drug Application Submitted for Continuous Subcutaneous Carbidopa/Levodopa Formulation
Diazepam Increased Time Between Cluster Intervals, Higher Dose Nusinersen Shows Extra Benefit, Lecanemab BLA Submitted